Kailera Therapeutics, Inc.(KLRA:US)
Market Cap$1.327B
Key Metrics
Price$11.25
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$111.83M
Total Assets$624.76M
Net Assets-$432.09M
Total Debt$10.47M
Key Metrics
Price$11.25
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$111.83M
Total Assets$624.76M
Net Assets-$432.09M
Total Debt$10.47M
Financials
| Name | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
Revenue | $0 | $0 |
Cost of Revenue | - | - |
Gross Profit | - | - |
| $84.66M | $20.46M | |
| Research and Development | $70.87M | $10.13M |
| Selling, General, and Administrative | $13.79M | $10.33M |
| Other Operating Expenses | - | - |
Operating Income | -$84.66M | -$20.46M |
| $5.8M | $2.48M | |
| Non-Operating Interest Income | $5.72M | $1.68M |
| Non-Operating Interest Expense | - | - |
| Other Income/Expense | $79K | $800K |
Income Before Tax | -$78.87M | -$17.98M |
Income Tax | - | - |
Net Income | -$78.87M | -$17.98M |
Minority Interests | - | - |
Preferred Stock Dividends | - | - |
Net Income to Common | -$78.87M | -$17.98M |
Shares Outstanding (Basic) | 117.95M | 117.95M |
Shares Outstanding (Diluted) | 117.95M | 117.95M |
EPS (Basic) | -$0.67 | -$0.15 |
EPS (Diluted) | -$0.67 | -$0.15 |
EBIT | -$84.66M | -$20.46M |
EBITDA | -$84.56M | -$20.4M |